Position & Policy Statements

Representing eye physicians and surgeons from coast to coast, the Canadian Ophthalmological Society (COS) advocates for optimal eye care for all Canadians, in part through the publication of the following position and policy statements:

• Evidence-based clinical practice guidelines for the periodic eye examination in children aged 0-5 years in Canada | Appendix (December 2019)
• Canadian Glaucoma Society evidence-based recommendations for the risk of acute angle closure glaucoma with routine use of hyoscine-n-butylbromide (Buscopan) for gastroenterological procedures (November 2019)
• Joint position paper calling for a complete ban on scleral tattooing and eyeball jewellery implantation in Manitoba (September 2018)
• Advisory statement regarding light therapy (photobiomodulation) for macular degeneration (October 2019)
• Use of nonpowder projectile weapons,
  including Airsoft, BB, nerf, paintball, and pellet guns (July 2019)
• Sustained funding to ensure access to anti-vascular endothelial growth factor drugs
• Medical use of cannabis for dry eye disease (November 2018)
• COS and Canadian Corneal, External Disease and Refractive Surgery Society statement to CTV/W5 (April 2019)
• Statement by COS regarding diversity and inclusion (April 2019)
• Medical use of cannabis for glaucoma (October 2018)
• Micro-invasive or minimally invasive glaucoma surgery (December 2017)
• Effects of electronic screens on children’s vision and recommendations for safe use
• Cuban treatment for retinitis pigmentosa
• COS privacy policy statement (November 2017)
• Guidelines for refractive surgery advertising (March 2013)
• Orthokeratology & myopia (June 2012)
• Valuation of uninsured services (June 2016)
• Vision standards for driving in Canada